TFF, GreenLight partner on powder form mRNA vaccine formulation

By The Science Advisory Board staff writers

March 9, 2021 -- To address the cold storage challenge of messenger RNA (mRNA) vaccines, GreenLight Biosciences and TFF Pharmaceuticals have entered into a feasibility and material transfer agreement to evaluate a shelf-stable dry powder formulation of GreenLight's COVID-19 mRNA vaccine candidate.

Upon successful completion of the feasibility study, a further stage of work will include non-needle administration methods for the GreenLight mRNA vaccine candidate in a dry powder form that could be administered via a nasal spray or lung inhalation.

Under the agreement, GreenLight is delivering its COVID-19 mRNA product candidate materials to TFF with the goal of identifying an optimal formulation of the GreenLight mRNA product candidate in a dry powder form. Utilizing TFF's thin-film freezing platform, the companies will work to formulate a product that has superior stability, maintains particle size of the encapsulated mRNA as well as high encapsulation efficiency, and has rapid reconstitution characteristics for injection.

Copyright © 2021
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here